WALTHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano”, or the “Company”) and Infinite Epigenetics ™ (“Infinite Epigenetics,”...
Believes the Proposed Transaction Represents a Misallocation of Corporate Resources That Would Significantly Dilute Existing Shareholders Finds It Deeply Concerning That...
Nano Dimension Conducted a Rigorous Multi-Month Strategic Review, Assessing Approximately 20 Companies Before Selecting Infinite Epigenetics as the Most Compelling Path to Long-Term Value Creation Proposed...
Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, “Murchinson” or “we”), a significant shareholder with approximately 7.4% of the outstanding shares of...
WALTHAM, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano” or the “Company”) today issued the following letter to shareholders from Chief...
Accelerating Progress Toward Unlocking and Maximizing Long-Term Shareholder Value Transaction Expected to Reduce Annualized Cash Burn by Approximately $15 Million WALTHAM, Mass., May 27, 2026...
It Is Time to Talk About Nano Dimension
Comments on Amended Schedule 13D Filing by Murchinson Strategic Alternatives Review Process Progresses WALTHAM, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) today...
Nano Dimension (NASDAQ:NNDM) executives used the company’s first-quarter 2026 earnings call to outline progress on a three-phase strategic plan that includes continued cost reductions, monetization of...
Recent Strategic Actions Expected to Reduce Annualized Cash Burn by Approximately $10 million Company Executing Three Phase Plan to Maximize Shareholder Value in 2026 and Beyond Full Year 2026...